Which Apple Chip Suppliers Will Face The Biggest Impact From iPhone Production Cuts?
Apple Inc (NASDAQ: AAPL) is reportedly looking to cut its iPhone production forecast for 2021 by 10 million due to supply chain issues.
Financial and Technology Stocks Making Headlines
Today kicks off the unofficial start of the fall earnings season with some big banks in focus, but before investors can dive into the earnings news they have to deal with some Apple (NASDAQ: AAPL) news.
Death Cross Looms Over Qorvo Investors
If history is any guide, there may be trouble ahead for shares of Qorvo(NASDAQ:QRVO). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Strengthening Positions In The Segment Of Professional Visualization Leads NVIDIA Shares To New Heights
In its Q2 report, Nvidia Inc. (NASDAQ: NVDA) beat expectations for revenue and earnings growth. Management has given a strong forecast for July-September 2021.
Morgan Stanley Maintains Overweight on Qorvo, Raises Price Target to $225
Morgan Stanley analyst Joseph Moore maintains Qorvo (NASDAQ:QRVO) with a Overweight and raises the price target from $223 to $225.
Rosenblatt Maintains Neutral on Qorvo, Raises Price Target to $215
Rosenblatt analyst Kevin Cassidy maintains Qorvo (NASDAQ:QRVO) with a Neutral and raises the price target from $200 to $215.
Oppenheimer Maintains Outperform on Qorvo, Raises Price Target to $250
Oppenheimer analyst Rick Schafer maintains Qorvo (NASDAQ:QRVO) with a Outperform and raises the price target from $220 to $250.
Qorvo: Q1 Earnings Insights
Shares of Qorvo (NASDAQ:QRVO) fell in after-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share rose 88.67% year over year to $2.83, which beat the estimate of $2.45.
Qorvo Q1 Adj. EPS $2.83 Beats $2.45 Estimate, Sales $1.11B Beat $1.08B Estimate
Qorvo (NASDAQ:QRVO) reported quarterly earnings of $2.83 per share which beat the analyst consensus estimate of $2.45 by 15.51 percent. This is a 88.67 percent increase over earnings of $1.50 per share from the same
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.